Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$247M |
| 2 |
Johnson & Johnson
JNJ
|
+$225M |
| 3 |
MON
Monsanto Co
MON
|
+$213M |
| 4 |
AET
Aetna Inc
AET
|
+$208M |
| 5 |
Broadcom
AVGO
|
+$176M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$227M |
| 2 |
Microsoft
MSFT
|
+$224M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$205M |
| 4 |
Nike
NKE
|
+$187M |
| 5 |
Pfizer
PFE
|
+$184M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.75% |
| 2 | Technology | 13.74% |
| 3 | Healthcare | 12.69% |
| 4 | Industrials | 11.51% |
| 5 | Consumer Discretionary | 8.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRQ
2176
DELISTED
Turquoise Hill Resources Ltd
TRQ
| $2.19M | ﹤0.01% |
68,350
+27,020
| +65% | +$869K |
|
|
KCG
2177
DELISTED
KCG Holdings, Inc.
KCG
| $2.19M | ﹤0.01% |
165,300
-90,900
| -35% | -$1.28M |
|
2178
Federal Realty Investment Trust
FRT
$10.3B
| $2.19M | ﹤0.01% |
+15,400
| New | +$2.19M |
|
2179
Hingham Institution for Saving
HIFS
$680M
| $2.18M | ﹤0.01% |
11,100
+2,200
| +25% | +$355K |
|
|
AHGP
2180
DELISTED
Alliance Holdings GP
AHGP
| $2.18M | ﹤0.01% |
77,655
+54,355
| +233% | +$1.55M |
|
2181
Farmers National Banc Corp
FMNB
$966M
| $2.18M | ﹤0.01% |
153,600
+24,300
| +19% | +$294K |
|
2182
Franklin Covey
FC
$229M
| $2.17M | ﹤0.01% |
107,900
+19,200
| +22% | +$374K |
|
2183
Akebia Therapeutics
AKBA
$242M
| $2.17M | ﹤0.01% |
208,600
+56,800
| +37% | +$489K |
|
2184
Frequency Electronics
FEIM
$863M
| $2.16M | ﹤0.01% |
200,000
-2,700
| -1% | -$27.1K |
|
|
SEP
2185
DELISTED
Spectra Engy Parters Lp
SEP
| $2.15M | ﹤0.01% |
46,789
-351,211
| -88% | -$15.3M |
|
|
WILN
2186
DELISTED
Wi-LAN Inc.
WILN
| $2.14M | ﹤0.01% |
1,312,700
+170,900
| +15% | +$251K |
|
2187
Calumet Specialty Products
CLMT
$4.19B
| $2.14M | ﹤0.01% |
534,700
+377,300
| +240% | +$1.54M |
|
2188
Lifeway Foods
LWAY
$395M
| $2.14M | ﹤0.01% |
185,700
+49,000
| +36% | +$690K |
|
2189
MakeMyTrip
MMYT
$5.68B
| $2.13M | ﹤0.01% |
+96,167
| New | +$2.39M |
|
|
CCR
2190
DELISTED
CONSOL Coal Resources LP
CCR
| $2.13M | ﹤0.01% |
116,965
+52,665
| +82% | +$952K |
|
2191
Matthews International
MATW
$725M
| $2.13M | ﹤0.01% |
27,753
+17,100
| +161% | +$1.15M |
|
2192
RB Global
RBA
$15.6B
| $2.13M | ﹤0.01% |
62,700
-13,900
| -18% | -$505K |
|
|
PDS
2193
Precision Drilling
PDS
$1.09B
| $2.13M | ﹤0.01% |
19,532
-476
| -2% | -$46.8K |
|
|
FFG
2194
DELISTED
FBL Financial Group
FFG
| $2.13M | ﹤0.01% |
27,200
-2,200
| -7% | -$158K |
|
2195
Piper Sandler
PIPR
$5.41B
| $2.12M | ﹤0.01% |
117,200
-39,600
| -25% | -$625K |
|
2196
WEX
WEX
$6.54B
| $2.12M | ﹤0.01% |
+19,018
| New | +$2.06M |
|
2197
Kadant
KAI
$3.95B
| $2.12M | ﹤0.01% |
34,600
-12,000
| -26% | -$691K |
|
2198
Element Solutions
ESI
$9.46B
| $2.11M | ﹤0.01% |
215,200
+28,100
| +15% | +$240K |
|
|
HDSN
2199
Hudson Technologies
HDSN
$239M
| $2.11M | ﹤0.01% |
263,400
+165,100
| +168% | +$1.17M |
|
2200
Genie Energy
GNE
$383M
| $2.11M | ﹤0.01% |
366,797
+18,400
| +5% | +$106K |
|
Similar funds
Jim Simons's Q4 2016 Portfolio in Review
As of Q4 2016, Jim Simons held 3,715 positions worth $63.2B, up 12% from $56.6B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.
Jim Simons deployed $5.07B of net new capital in Q4 2016, opening 418 new positions and adding to 1,792 existing holdings. Its largest new stake was Broadcom: 10,144,960 shares worth $179M.
By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 12% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $227M trimmed.
- Jim Simons's largest Q4 2016 buy was Broadcom: 10,144,960 shares worth $179M.
- Jim Simons added most to Gilead Sciences in Q4 2016, an estimated $247M increase.
- Jim Simons's biggest Q4 2016 reduction was Bristol-Myers Squibb, cutting an estimated $227M.
- Jim Simons fully exited Alphabet (Google) Class C in Q4 2016, selling an estimated $205M.
- Jim Simons's ten largest holdings make up 7.2% of its $63.2B portfolio in Q4 2016.
- Jim Simons opened 418 new positions and closed 494 in Q4 2016.
- Jim Simons's portfolio value rose 12% quarter-over-quarter to $63.2B.
Based on Renaissance Technologies's 13F filing for Q4 2016, filed 13 Feb 2017.